Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 8,701–8,725 of 27,380 studies, newest first · page 349 of 1096.

July 2022 14

  1. 2022-07-05

    Cognitive and behavioral effects of hearing loss

    ✓ Peer-reviewed Risk factors Current opinion in otolaryngology & head and neck surgery

    Key finding: Hearing loss is one of the largest modifiable risk factors for developing dementia, accounting for up to 9% of the overall modifiable risk. +1 more finding

  2. 2022-07-05

    Alzheimer's disease cerebrospinal fluid biomarkers differentiate patients with Creutzfeldt-Jakob disease and autoimmune encephalitis

    ✓ Peer-reviewed Tau biomarkers European journal of neurology

    Key finding: Autoimmune encephalitis (AE) is a potentially treatable cause of rapidly progressive dementia that may mimic Creutzfeldt-Jakob disease (CJD). +3 more findings

  3. 2022-07-03

    Adherence to MIND Diet, Genetic Susceptibility, and Incident Dementia in Three US Cohorts

    ✓ Peer-reviewed Prevention trials Nutrients

    Key finding: Higher adherence to MIND and lower GS were associated with a lower risk of dementia in MAP and WHIMS and a slower rate of cognitive decline in MAP (p < 0.05). +2 more findings

  4. 2022-07-02

    Spermidine reduces neuroinflammation and soluble amyloid beta in an Alzheimer's disease mouse model

    ✓ Peer-reviewed Inflammation and the immune system Journal of neuroinflammation

    Key finding: Oral treatment of the amyloid prone AD-like APPPS1 mice with spermidine reduced neurotoxic soluble Aβ and decreased AD-associated neuroinflammation. +4 more findings

  5. 2022-07-01

    Type-I-interferon signaling drives microglial dysfunction and senescence in human iPSC models of Down syndrome and Alzheimer's disease

    ✓ Peer-reviewed Down syndrome and Alzheimer's Cell stem cell

    Key finding: Our findings provide in vivo evidence that human microglia respond to pathological tau by exhibiting dystrophic phenotypes.

  6. 2022-07-01

    Neuropsychiatric Ramifications of Severe COVID-19 and Other Severe Acute Respiratory Infections

    ✓ Peer-reviewed Digital health tools JAMA psychiatry

    Key finding: In this cohort study of data from 8.38 million adults (4.18 million women, 4.20 million men; mean [SD] age 49.18 [18.45] years); 16 679 (0.02%) survived a hospital admission for SARI, and 32 525 (0.03%) survived a hospital admission for COVID-19. +3 more findings

  7. 2022-07-01

    Reimagining cholinergic therapy for Alzheimer's disease

    ✓ Peer-reviewed Treatments Brain : a journal of neurology

    Key finding: It includes a new and updated overview of the involvement of muscarinic receptors in Alzheimer's disease as well as the recent development of new and highly selective M1 muscarinic receptor agonists with disease-modifying potential. +4 more findings

  8. 2022-07-01
  9. 2022-07-01
  10. 2022-07-01

    Getting Ready for Continence Certification

    ✓ Peer-reviewed Health systems and care delivery Journal of Wound Ostomy and Continence Nursing

    Key finding: The most significant evidence for value added by WOC nurses was for QoL improvement and was further demonstrated through improved incontinence-specific outcomes. +2 more findings

  11. 2022-07-01

    Covid-19 and Aging: Challenges and Opportunities

    ✓ Peer-reviewed Health systems and care delivery The Journals of Gerontology Series A

    Key finding: Very early in the course of the Covid-19 pandemic, it became glaringly clear that older persons were at significantly increased risk of infection, severe illness, hospitalization, intensive care and respiratory support, and death. +4 more findings

  12. 2022-07-01

    Variation in Population Attributable Fraction of Dementia Associated With Potentially Modifiable Risk Factors by Race and Ethnicity in the US

    ✓ Peer-reviewed Prevention and risk JAMA network open

    Key finding: A large fraction of dementia cases in the US were associated with potentially modifiable risk factors, especially for Black and Hispanic individuals. +3 more findings

  13. 2022-07-01

    The 2022 hormone therapy position statement of The North American Menopause Society

    ✓ Peer-reviewed Prevention and risk Menopause (New York, N.Y.)

    Key finding: "The 2022 Hormone Therapy Position Statement of The North American Menopause Society" (NAMS) updates "The 2017 Hormone Therapy Position Statement of The North American Menopause Society" and identifies future research needs. +4 more findings

  14. 2022-07-01

    Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease

    ✓ Peer-reviewed Genetics JAMA neurology

    Key finding: In this genetic association study, a novel variant associated with AD was identified: R251G always coinherited with ε4 on the APOE gene, which mitigates the ε4-associated AD risk. +4 more findings

June 2022 11

  1. 2022-06-30

    Microglia Phenotypes in Aging and Neurodegenerative Diseases

    ✓ Peer-reviewed Genetics Cells

    Key finding: However, there is a consensus that microglia play a biphasic role in pathological conditions, with detrimental and protective phenotypes, and the overall response of microglia and the activation of different phenotypes depends on the nature and duration of the inflammatory insult, as well as the stage of disease development.

  2. 2022-06-30

    Study protocol for the Alzheimer and music therapy study: An RCT to compare the efficacy of music therapy and physical activity on brain plasticity, depressive symptoms, and cognitive decline, in a population with and at risk for Alzheimer's disease

    ✓ Peer-reviewed Treatments PloS one

    Key finding: Addressing the need for rigorous longitudinal data for the effectiveness of music therapy in people with and at risk for developing AD, this trial aims to enhance knowledge regarding cost-effective interventions with potentially high clinical applicability. +4 more findings

  3. 2022-06-29

    Area Deprivation Index as a Surrogate of Resilience in Aging and Dementia

    ✓ Peer-reviewed Risk factors Frontiers in Psychology

    Key finding: The goal of this mini-review is three-fold: (1) to summarize the current literature on ADI and its link to cognitive impairment outcomes; (2) suggest possible mechanisms through which ADI may have an impact on AD/ADRD outcomes, and (3) discuss important considerations when studying relations between ADI and cognitive as well as brain health. +4 more findings

  4. 2022-06-29

    Sex differences in plasma p-tau181 associations with Alzheimer's disease biomarkers, cognitive decline, and clinical progression

    ✓ Peer-reviewed Long-term cohort studies Molecular psychiatry

    Key finding: Some studies have found that higher levels of tau biomarkers are more strongly associated with clinical AD, cognitive decline and neurodegeneration in women than in men. +3 more findings

  5. 2022-06-27

    A shared disease-associated oligodendrocyte signature among multiple CNS pathologies

    ✓ Peer-reviewed Genetics Nature neuroscience

    Key finding: Using quantitative spatial analysis of mouse and postmortem human brain tissues, we found that oligodendrocytes expressing a key DOL marker (SERPINA3N/SERPINA3 accordingly) are present in the cortex in areas of brain damage and are enriched near Aβ plaques.

  6. 2022-06-26

    Four Distinct Subtypes of Alzheimer's Disease Based on Resting-State Connectivity Biomarkers

    ✓ Peer-reviewed Brain scans and imaging Biological psychiatry

    Key finding: Individuals with AD were clustered into 4 subtypes reproducibly, which included those with 1) diffuse and mild functional connectivity disruption (subtype 1), 2) predominantly decreased connectivity in the default mode network accompanied by an increase in the prefrontal circuit (subtype 2), 3) predominantly decreased connectivity in the anterior cingulate cortex accompanied by an increase in prefrontal cortex connectivity (subtype 3), and 4) predominantly decreased connectivity in the basal ganglia accompanied by an increase in prefrontal cortex connectivity (subtype 4). +2 more findings

  7. 2022-06-25

    Functional connectivity correlates of reduced goal-directed behaviors in behavioural variant frontotemporal dementia

    ✓ Peer-reviewed Brain scans and imaging Brain structure & function

    Key finding: Apathy in bvFTD was associated with lower time spent in activity combined with walking episodes of higher frequency, lower acceleration and higher duration. +1 more finding

  8. 2022-06-25

    Metacognition, cortical thickness, and tauopathy in aging

    ✓ Peer-reviewed Brain scans and imaging Neurobiology of aging

    Key finding: We found that worse performers had lower self-appraisal ratings, but still overestimated their performance, consistent with the Dunning-Kruger effect. +3 more findings

  9. 2022-06-25

    GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight

    ✓ Peer-reviewed Drug development Cells

    Key finding: In this context, a new class of pharmacological agents that achieve improved glycaemic control via the glucagon-like peptide 1 (GLP-1) receptor has attracted significant attention as putative neuroprotective agents. +1 more finding

  10. 2022-06-24

    Functional Connectivity Dynamics Altered of the Resting Brain in Subjective Cognitive Decline

    ✓ Peer-reviewed Brain scans and imaging Frontiers in aging neuroscience

    Key finding: When comparing SCD (N = 40) with NC (N = 45), mdALFFmean decreased at right inferior parietal lobule (IPL) of the frontoparietal network (FPN). +4 more findings

  11. 2022-06-23

    The role of triggering receptor expressed on myeloid cells 2 in Parkinson's disease and other neurodegenerative disorders

    ✓ Peer-reviewed TREM2 and immune genetics Behavioural brain research

    Key finding: In recent years, triggering factor expressed on myeloid cells (TREM2) gained attention in the field of neurodegeneration as it could be associated with different neurodegenerative disorders.

Browse the library by subject, with the full score breakdown →